KENNEDY MCDONNELL: Open Payments
NPI 1093462251 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$914 in 24 payments from 15 companies in 2025. Trend: 2023 $417 · 2024 $198 · 2025 $914
Food & beverage: $821Education: $93
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 3 | $249 |
| JAZZ PHARMACEUTICALS INC. | 1 | $121 |
| PFIZER INC. | 3 | $87 |
| AstraZeneca Pharmaceuticals LP | 4 | $86 |
| Genentech USA, Inc. | 2 | $58 |
| Lilly USA, LLC | 2 | $54 |
| GENZYME CORPORATION | 1 | $44 |
| EMD Serono, Inc. | 1 | $34 |
| SpringWorks Therapeutics, Inc. | 1 | $33 |
| Syndax Pharmaceuticals, Inc. | 1 | $33 |
Products named: Niktimvo, ZEPZELCA, LYNPARZA, Itovebi, VERZENIO, WAYRILZ, TUKYSA, OGSIVEO.
Industry payments across IL — which companies pay providers there.
